Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Shares Repurchased: 2017-2018

Historic Shares Repurchased for Northwest Biotherapeutics (NWBO) over the last 2 years, with Dec 2018 value amounting to $855,000.

  • Northwest Biotherapeutics' Shares Repurchased rose 21.28% to $855,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $3.3 million, marking a year-over-year increase of 74.89%. This contributed to the annual value of $3.3 million for FY2018, which is 74.84% up from last year.
  • According to the latest figures from Q4 2018, Northwest Biotherapeutics' Shares Repurchased is $855,000, which was up 20.76% from $708,000 recorded in Q3 2018.
  • Northwest Biotherapeutics' Shares Repurchased's 5-year high stood at $1.1 million during Q1 2018, with a 5-year trough of $2,000 in Q1 2017.
  • Moreover, its 2-year median value for Shares Repurchased was $706,500 (2017), whereas its average is $650,125.
  • Data for Northwest Biotherapeutics' Shares Repurchased shows a peak YoY increase of 53,600.00% (in 2018) and a maximum YoY decrease of 3.80% (in 2018) over the last 5 years.
  • Over the past 2 years, Northwest Biotherapeutics' Shares Repurchased (Quarterly) stood at $705,000 in 2017, then rose by 21.28% to $855,000 in 2018.
  • Its Shares Repurchased stands at $855,000 for Q4 2018, versus $708,000 for Q3 2018 and $672,000 for Q2 2018.